GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » EV-to-EBITDA

Nuvation Bio (Nuvation Bio) EV-to-EBITDA : -11.88 (As of Apr. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nuvation Bio's enterprise value is $1,107.14 Mil. Nuvation Bio's EBITDA for the trailing twelve months (TTM) ended in Sep. 2021 was $-93.18 Mil. Therefore, Nuvation Bio's EV-to-EBITDA for today is -11.88.

The historical rank and industry rank for Nuvation Bio's EV-to-EBITDA or its related term are showing as below:

NUVB' s EV-to-EBITDA Range Over the Past 10 Years
Min: -52.76   Med: 0   Max: 0
Current: -12.19

NUVB's EV-to-EBITDA is not ranked
in the Biotechnology industry.
Industry Median: 9.22 vs NUVB: -12.19

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Nuvation Bio's stock price is $5.435. Nuvation Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.440. Therefore, Nuvation Bio's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Nuvation Bio EV-to-EBITDA Historical Data

The historical data trend for Nuvation Bio's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio EV-to-EBITDA Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
EV-to-EBITDA
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
EV-to-EBITDA Get a 7-Day Free Trial - -77.91 -29.36 -21.60 -

Competitive Comparison of Nuvation Bio's EV-to-EBITDA

For the Biotechnology subindustry, Nuvation Bio's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's EV-to-EBITDA falls into.



Nuvation Bio EV-to-EBITDA Calculation

Nuvation Bio's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1107.142/-93.177
=-11.88

Nuvation Bio's current Enterprise Value is $1,107.14 Mil.
Nuvation Bio's EBITDA for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-93.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nuvation Bio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.435/-0.440
=At Loss

Nuvation Bio's share price for today is $5.435.
Nuvation Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.440.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Nuvation Bio EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.